DaVita Eyes Expansion Into Brazil

Photo of Trey Thoelcke
By Trey Thoelcke Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

On Wednesday, DaVita HealthCare Partners Inc. (NYSE: DVA) announced that it will be expanding its footprint in emerging markets by beginning operations in Brazil. This leading global provider of kidney care services already operates in 11 countries, serving more than 1.5 million patients.

DaVita says it will help Brazilian physicians grow their practice by offering access to a worldwide network of experts, best-in-class training programs and the most advanced clinical and administrative service standards.

More than 110,000 Brazilians require dialysis, and studies suggest that number will increase with the rising prevalence of chronic kidney disease in the country.

Dennis Kogod, CEO of DaVita’s international operations, said:

In addition to bringing DaVita’s leading kidney care services to the country, we look forward to partnering with the Brazilian government and payors in establishing and expanding integrated care functions.

Besides being a Fortune 500 company, DaVita is a significant holding of Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-B) as well. As of the most recent filing, the stake was more than 38.5 million shares. That was almost 18% of the outstanding shares, making Berkshire the largest single holder. Berkshire had raised its stake in DaVita on and off until earlier this year, and it has a standstill agreement not to buy more than 25% of the company.

DaVita shares have had a rough ride this summer, falling more than 10% in the past three months and reaching a new 52-week low this week. The S&P 500 has fallen more than 8% in that time. The stock closed at $71.18 on Tuesday, within a 52-week range of $70.12 to $85.17. The analysts’ mean price target for the shares is $85.60.

ALSO READ: Argus Sees 3 Top Health and Biotech Stocks as Oversold

Photo of Trey Thoelcke
About the Author Trey Thoelcke →

Trey has been an editor and author at 24/7 Wall St. for more than a decade, where he has published thousands of articles analyzing corporate earnings, dividend stocks, short interest, insider buying, private equity, and market trends. His comprehensive coverage spans the full spectrum of financial markets, from blue-chip stalwarts to emerging growth companies.

Beyond 24/7 Wall St., Trey has created and edited financial content for Benzinga and AOL's BloggingStocks, contributing additional hundreds of articles to the investment community. He previously oversaw the 24/7 Climate Insights site, managing editorial operations and content strategy, and currently oversees and creates content for My Investing News.

Trey's editorial expertise extends across multiple publishing environments. He served as production editor at Dearborn Financial Publishing and development editor at Kaplan, where he helped shape financial education materials. Earlier in his career, he worked as a writer-producer at SVE. His freelance editing portfolio includes work for prestigious clients such as Sage Publications, Rand McNally, the Institute for Supply Management, the American Library Association, Eggplant Literary Productions, and Spiegel.

Outside of financial journalism, Trey writes fiction and has been an active member of the writing community for years, overseeing a long-running critique group and moderating workshop sessions at regional conventions. He lives with his family in an old house in the Midwest.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618